Reasons for underutilization of bariatric surgery: the role of insurance benefit design H Gasoyan, G Tajeu, MT Halpern, DB Sarwer Surgery for Obesity and Related Diseases 15 (1), 146-151, 2019 | 119 | 2019 |
Do insurance-mandated precertification criteria and insurance plan type determine the utilization of bariatric surgery among individuals with private insurance? H Gasoyan, R Soans, JK Ibrahim, WE Aaronson, DB Sarwer Medical care 58 (11), 952-957, 2020 | 24 | 2020 |
Impact of insurance plan design on bariatric surgery utilization H Gasoyan, MT Halpern, G Tajeu, DB Sarwer Surgery for Obesity and Related Diseases 15 (10), 1812-1818, 2019 | 23 | 2019 |
Role of weight bias and patient–physician communication in the underutilization of bariatric surgery DB Sarwer, H Gasoyan, SB Bass, JC Spitzer, R Soans, DJ Rubin Surgery for Obesity and Related Diseases 17 (11), 1926-1932, 2021 | 16 | 2021 |
Strengthening legal frameworks for vaccination: the experiences of Armenia, Georgia, and Moldova SP Trumbo, D Silver, O Domenti, H Gasoyan, E Paatashvili, BG Gellin, ... Vaccine 37 (35), 4840-4847, 2019 | 12 | 2019 |
The role of health insurance characteristics in utilization of bariatric surgery H Gasoyan, JK Ibrahim, WE Aaronson, DB Sarwer Surgery for Obesity and Related Diseases 17 (5), 860-868, 2021 | 9 | 2021 |
School-based preventive dental program in rural communities of the republic of Armenia H Gasoyan, A Safaryan, L Sahakyan, N Gasoyan, WE Aaronson, ... Frontiers in Public Health 7, 243, 2019 | 8 | 2019 |
Left hemispatial neglect with a splenial lesion T Kesayan, H Gasoyan, KM Heilman Neurocase 24 (4), 220-226, 2018 | 7 | 2018 |
Early‐and later‐stage persistence with antiobesity medications: a retrospective cohort study H Gasoyan, ER Pfoh, R Schulte, P Le, MB Rothberg Obesity 32 (3), 486-493, 2024 | 6 | 2024 |
Disparities In Diabetes-Related Lower Extremity Amputations In The United States: A Systematic Review: Systematic review examines disparities in diabetes-related lower … H Gasoyan, SR Hussain, WG Wright, DB Sarwer Health Affairs 41 (7), 985-993, 2022 | 6 | 2022 |
Addressing insurance‐related barriers to novel antiobesity medications: lessons to be learned from bariatric surgery H Gasoyan, DB Sarwer Obesity 30 (12), 2338-2339, 2022 | 4 | 2022 |
Error by omission: A lack of integration across implementation and use in structuring health information technology contracts TR Martin, H Gasoyan, DJ Wierz Health Informatics Journal 26 (3), 2202-2212, 2020 | 4 | 2020 |
Metrics to evaluate the performance of cancer center leadership: a systematic review MT Halpern, H Gasoyan, WE Aaronson Journal of Healthcare Management 65 (3), 217-235, 2020 | 4 | 2020 |
10-year weight loss outcomes after Roux-en-Y gastric bypass and attendance at follow-up visits: a single-center study SH Chang, H Gasoyan, M Wang, N Ackermann, X Liu, C Herrick, ... Surgery for Obesity and Related Diseases 18 (4), 538-545, 2022 | 3 | 2022 |
A national survey assessing health information exchange: readiness for changes to Veterans Affairs access standards TR Martin, H Gasoyan, G Pirrotta, R Mathew Perspectives in Health Information Management 18 (3), 2021 | 3 | 2021 |
The potential implications of “Medicare for All” and “public option” for bariatric surgery H Gasoyan, R Soans, DB Sarwer Surgery for Obesity and Related Diseases 16 (8), 1160-1162, 2020 | 3 | 2020 |
Association of patient characteristics and insurance type with anti‐obesity medications prescribing and fills H Gasoyan, ER Pfoh, R Schulte, E Sullivan, P Le, MB Rothberg Diabetes, Obesity and Metabolism, 2024 | 2 | 2024 |
Association between insurance-mandated precertification criteria and inpatient healthcare utilization during 1 year after bariatric surgery H Gasoyan, RS Soans, JK Ibrahim, WE Aaronson, DB Sarwer Surgery for Obesity and Related Diseases 18 (2), 271-280, 2022 | 2 | 2022 |
A framework for contracted health IT performance assessments TR Martin, H Gasoyan, DJ Wierz Hospital Topics 97 (1), 15-22, 2019 | 2 | 2019 |
Association of Insurance Characteristics and Persistence with Anti-Obesity and GLP-1 RA Medications H Gasoyan, R Schulte, P Le, E Pfoh, M Rothberg OBESITY 31, 36-37, 2023 | 1 | 2023 |